Cargando...
EGFR-TKI resistance and MAP17 are associated with cancer stem cell like properties
Patients with non-small-cell lung cancer (NSCLC) with sensitive epidermal growth factor receptor (EGFR) mutations generally react well to tyrosine kinase inhibitors (TKIs). However acquired resistance eventually occurs. Several mechanisms contribute to the resistance including T790M mutation, c-Met...
Guardado en:
| Publicado en: | Oncol Lett |
|---|---|
| Autores principales: | , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
D.A. Spandidos
2018
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5876419/ https://ncbi.nlm.nih.gov/pubmed/29616128 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2018.8129 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|